Pebblebrook Sells Chamberlain West Hollywood Hotel for $43.5M
Pebblebrook Hotel Trust completed the sale of the 115-room Chamberlain West Hollywood Hotel for $43.5 million. Proceeds from the sale will be used to reduce outstanding net debt and preferred equity, opportunistically repurchase common shares, and support other high-return capital allocation priorities. The company also updated its second-quarter and full-year 2026 outlook to reflect the property disposition, including minor adjustments to financial metrics. The transaction involved retiring $33.7 million in preferred shares at a 23% discount.
Key Highlights
- Pebblebrook sold Chamberlain West Hollywood Hotel for $43.5 million.
- Hotel generated $3.0M EBITDA and $2.6M NOI (trailing 12 months).
- Sale price implies 14.5x EBITDA multiple and 5.9% NOI cap rate.
- Retired $33.7M preferred shares at 23% discount ($26.1M value).
- Reduced preferred equity outstanding to $720.6 million.
- Updated FY2026 Adjusted EBITDAre outlook to $334.5M-$346.5M.
- Updated FY2026 Adjusted FFO per share outlook to $1.60-$1.70.
- Since 2021, company sold over $1.0 billion in properties.
Price Impact
More from PEB
Pebblebrook Hotel Trust Q2 2026 Earnings Call Set for July 30
Pebblebrook Hotel Trust Amends Declaration for Trustee Removal Rights
PEB Q1 Adj FFO $0.32, +100%; Same-Prop Hotel EBITDA $82.2M; Raises 2026 Outlook